LFWD

+ Watchlist + Portfolio

Lifeward Ltd.

GridBrain — Sign in

GridSentinel — Sign in

GridAegis — Sign in

Key Metrics

Previous Close: $7.21
52-Week Range: $4.14 – $10.56
Market Cap: $20.76M
P/E (TTM): —
EPS (TTM): -14.66
Dividend Yield: —

Advanced Metrics

Price/Book: 3.24
PEG Ratio: —
Return on Equity: -225.65%
Return on Assets: -47.26%
Gross Margin: 35.96%
Operating Margin: -62.69%
Profit Margin: -141.28%
Current Ratio: 2.33
Debt/Equity: 0.57
Total Debt: $6.99M
Free Cash Flow: $-7.95M
Revenue Growth: 15.70%
Earnings Growth: —
Enterprise Value: $18.30M

LFWD Income statement, annual periods, in USD
USD	FY2022	FY2023	FY2024	FY2025
Revenue	$5.51M	$13.85M	$25.66M	$22.03M
Cost of Revenue	$3.61M	$9.40M	$17.45M	$13.61M
Gross Profit	$1.91M	$4.45M	$8.22M	$8.43M
Research & Development	$4.03M	$4.15M	$4.63M	$3.25M
Selling, General & Admin	$16.98M	$23.92M	$23.14M	$22.07M
Operating Expenses	$21.01M	$28.07M	$27.77M	$25.32M
Operating Income	-$19.10M	-$23.61M	-$19.55M	-$16.89M
EBITDA	-$18.90M	-$21.77M	-$15.71M	-$16.56M
Pretax Income	-$19.10M	-$22.14M	-$28.90M	-$19.97M
Income Tax	$467.00K	-$12.00K	$43.00K	-$55.00K
Net Income	-$19.57M	-$22.13M	-$28.94M	-$19.91M
Diluted EPS	-26.35	-31.13	-39.96	-17.16
Diluted Shares	742604	710941	724272	1.16M

LFWD Balance Sheet statement, annual periods, in USD
USD	FY2022	FY2023	FY2024	FY2025
Cash & Equivalents	$67.90M	$28.08M	$6.75M	$2.17M
Receivables	$1.04M	$3.12M	$6.00M	$6.14M
Inventory	$2.93M	$5.65M	$6.72M	$5.73M
Current Assets	$72.51M	$39.22M	$21.29M	$15.81M
Total Assets	$74.24M	$63.19M	$30.49M	$22.90M
Current Liabilities	$4.78M	$11.79M	$10.22M	$12.04M
Total Debt	$897.00K	$1.90M	$880.00K	$4.39M
Total Liabilities	$6.07M	$16.68M	$11.64M	$14.49M
Retained Earnings	-$213.75M	-$235.88M	-$264.82M	-$284.74M
Shareholders' Equity	$68.17M	$46.51M	$18.85M	$8.41M
Working Capital	$67.73M	$27.43M	$11.07M	$3.77M
Net Debt	—	—	—	$634.00K

LFWD Cash Flow statement, annual periods, in USD
USD	FY2022	FY2023	FY2024	FY2025
Operating Cash Flow	-$17.89M	-$20.67M	-$21.72M	-$16.83M
Capital Expenditure	-$25.00K	-$81.00K	—	-$16.00K
Free Cash Flow	-$17.92M	-$20.75M	-$21.72M	-$16.84M
Depreciation & Amortisation	$202.00K	$1.85M	$3.84M	$333.00K
Stock-Based Compensation	$993.00K	$1.33M	$1.28M	$743.00K
Investing Cash Flow	-$25.00K	-$18.15M	$0.00	-$16.00K
Financing Cash Flow	-$2.50M	-$992.00K	$0.00	$12.20M
Share Repurchases	-$2.50M	-$992.00K	$0.00	$0.00
Net Change in Cash	-$20.42M	-$39.81M	-$21.72M	-$4.64M

LFWD Income statement, quarterly periods, in USD
USD	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026
Revenue	$5.03M	$5.72M	$6.20M	$5.08M	$3.92M
Cost of Revenue	$2.91M	$3.21M	$3.49M	$3.99M	$2.58M
Gross Profit	$2.12M	$2.51M	$2.71M	$1.09M	$1.34M
Research & Development	$918.00K	$767.00K	$721.00K	$843.00K	$5.84M
Selling, General & Admin	$6.06M	$5.52M	$5.13M	$5.36M	$5.84M
Operating Expenses	$6.97M	$6.29M	$5.85M	$6.21M	$11.68M
Operating Income	-$4.85M	-$3.78M	-$3.14M	-$5.12M	-$10.34M
EBITDA	-$4.76M	-$3.69M	-$3.06M	-$5.05M	-$4.85M
Pretax Income	-$4.82M	-$6.56M	-$3.16M	-$5.42M	-$10.79M
Income Tax	$11.00K	$0.00	$7.00K	-$73.00K	$6.00K
Net Income	-$4.83M	-$6.56M	-$3.17M	-$5.35M	-$10.79M
Diluted EPS	-5.53	-6.96	-2.40	-3.60	-6.70
Diluted Shares	873845	935785	1.34M	1.49M	1.61M

LFWD Balance Sheet statement, quarterly periods, in USD
USD	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026
Cash & Equivalents	$5.73M	$5.14M	$1.96M	$2.17M	$11.42M
Receivables	$5.17M	$5.86M	$6.13M	$6.14M	$6.03M
Inventory	$6.80M	$7.62M	$7.11M	$5.73M	$6.25M
Current Assets	$19.82M	$20.71M	$17.35M	$15.81M	$25.56M
Total Assets	$28.81M	$26.78M	$23.17M	$22.90M	$33.42M
Current Liabilities	$9.07M	$10.36M	$9.05M	$12.04M	$10.63M
Long-Term Debt	—	—	—	—	$7.28M
Total Debt	$619.00K	$375.00K	$237.00K	$4.39M	$8.81M
Total Liabilities	$10.35M	$11.67M	$10.41M	$14.49M	$27.13M
Retained Earnings	-$269.66M	-$276.22M	-$279.39M	-$284.74M	-$295.53M
Shareholders' Equity	$18.46M	$15.11M	$12.76M	$8.41M	$6.29M
Working Capital	$10.75M	$10.35M	$8.29M	$3.77M	$14.92M
Net Debt	—	—	—	$634.00K	—

LFWD Cash Flow statement, quarterly periods, in USD
USD	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026
Operating Cash Flow	-$5.49M	-$3.94M	-$3.84M	-$3.56M	-$3.67M
Capital Expenditure	-$5.00K	—	—	-$11.00K	—
Free Cash Flow	-$5.50M	-$3.94M	-$3.84M	-$3.57M	-$3.67M
Depreciation & Amortisation	$90.00K	$88.00K	$83.00K	$72.00K	$5.01M
Stock-Based Compensation	$220.00K	$182.00K	$174.00K	$167.00K	$177.00K
Investing Cash Flow	-$5.00K	$0.00	$0.00	-$11.00K	$6.50M
Financing Cash Flow	$4.47M	$3.31M	$646.00K	$3.78M	$6.42M
Net Change in Cash	-$1.03M	-$628.00K	-$3.20M	$212.00K	$9.25M

Market Snapshot

About

Lifeward Ltd. is a medical technology company developing exoskeleton systems for individuals with mobility impairments. The company's flagship product is a wearable robotic exoskeleton designed to enable people with lower-limb disabilities to stand, walk, and climb stairs. Lifeward focuses on advancing rehabilitation technology and improving quality of life for those with spinal cord injuries and other mobility challenges.